PQS 22/23

Declaration Period

This is a reminder that the declaration period is

between 9am on Monday 6th February 2023 and 11.59pm on 3rd March 2023.

You must have evidence to demonstrate meeting the gateway criteria and the domains that you have claimed for by the end of 31st March 2023.

Please see a summary of domains below and some useful links to assist when completing the modules.

Gateway Criteria

To qualify for the PQS 2022/23 payment, contractors will have to meet the following TWO gateway criteria by the end of 31st March 2023. 1. You must have delivered a minimum of 20 NMS between 1st April 2022 and end of 31st March 2023. 2. Write a new patient safety report. To help you, here are: Guide – Completing the Patient Safety Report Template – Monthly patient safety report template (Word) Template –Patient safety report template (Word)

Domain Summaries  

Domain 1 – Risk management and safeguarding
Domain 2 – Respiratory
Domain 3 – Healthy living support
Domain 4 – Prevention
Domain5 – Addressing unwarranted variation in care
Free Virtual Outcomes PQS Ready Link and Other Useful Links

Domain 1 – Risk management and safeguarding 

Risk review update  

You need to…  

Safeguarding level 3 webinar

Domestic abuse prevention

All patient-facing staff that provide advice on medicines or healthcare working at the pharmacy on the day of the declaration must have satisfactorily:

At least one person responsible for the premises must have:

  Domain 2 – Respiratory

Start now…!  

Inhaler technique checks

  • Evidence pharmacy staff have offered the NMS, with the appropriate inhaler technique check, to all patients presenting with a prescription for a new inhaler.
  • All pharmacists working at the pharmacy who are providing NMS, with the appropriate inhaler technique check, must:

Inhaler waste management

  • All patient-facing pharmacy staff have been trained on the reasons why used, unwanted and expired inhalers should be returned to the pharmacy for safe disposal and the adverse effects on the environment when inhalers are disposed of in domestic waste.
  • Evidence that staff have spoken with all patients, for whom they have dispensed an inhaler between 10 October 2022 and the day of the declaration, about the environmental benefits of them returning all unwanted and used inhaler devices to a community pharmacy for safe and environmentally friendly disposal. Discussions can be supplemented with other communication methods such as leaflets, emails and texts.

Use of a spacer in patients aged 5-15 years

Evidence that you have:

  • checked that all children aged 5 to 15 prescribed a press and breathe pressurised MDI for asthma have a spacer device, where appropriate, in line with NICE TA38; and
  • referred children aged 5 to 15 with asthma to an appropriate healthcare professional where this is not the case.

Domain 3 – Healthy living support

Weight management

You need to…

  • Complete (all non-registered patient facing staff who provide health advice) the All Our Health bitesize training and assessments on Adult Obesity and Childhood Obesity to gain a broader understanding of the causes and effects of obesity.
  • Complete (all registered pharmacy professionals) sections one and three of the CPPE Weight management for adults: understanding the management of obesity e-learning and e-assessment.
  • Update your existing weight management action plan or complete a new weight management action plan (if you did not declare as meeting the weight management criteria for a previous PQS) of how they would assist a person who would like support with their weight.

Pharmacy teams must proactively discuss weight management with a minimum of 25 patients.   Pharmacy teams are encouraged to review the former Public Health England Let’s Talk About Weight infographic and Let’s talk about weight: a step-by-step guide to brief interventions with adults for health and care professionals guidance for support with initiating and managing conversations with people about weight management.

  • A competent individual within the pharmacy (for example, registered pharmacy professional or nominated team member) must be able to offer to measure a patient’s Body Mass Index (BMI), using an appropriate BMI calculator such as, the NHS healthy weight calculator, and measure waist circumference. This should include explaining the purpose of measuring BMI and waist circumference. Pharmacies must have access to equipment to accurately measure height, weight and waist circumference.


  • Pharmacies must support those who wish to lose weight through advice and referral to the NHS Digital Weight Management Programme or Local Authority funded tier 2 weight management services (where the individual meets the criteria for referral).

To gain the maximum number of points for this criterion (1 point for a band 1 pharmacy or 20 points for a band 2-6 pharmacy), the pharmacy must have referred at least four patients (who meet the criteria for referral)

to either a Local Authority funded tier 2 weight management service

For a full list of Tier 2 Weight Management Services across Lancashire, please click here.

Blackburn with Darwen – Weight Management – BwD Healthy Living (healthylivingbwd.org.uk)
Blackpool – Specialist Weight Management Service | Blackpool Teaching Hospitals NHS Foundation Trust (bfwh.nhs.uk)

or the NHS Digital Weight Management Programme between 10th October 2022 and 31st March 2023.  

Domain 4 – Prevention  

You need to…

Review pharmacy staff practice, to include two TARGET leaflets;

to help you assess patients presenting to the pharmacy with suspected UTI or upper RTI without a prescription, provide tailored advice to patients and promote awareness of antimicrobial resistance and antimicrobial stewardship. The leaflets are available in multiple languages.   This review must be completed by the end of 31st March 2023 and must be carried out over four weeks with a minimum of 15 patients for each leaflet, or up to eight weeks if the minimum number of patients are not achieved within four weeks for each leaflet.   You must collect data…   Data collection forms here –       NHS England – Data collection form for UTI consultations with women under 65 years NHS England – Data collection form for upper RTI consultations with patients   (Where no patients are identified for the review, the contractor will still be eligible for payment if they can evidence that they have robustly attempted to identify suitable patients).   By 31st March 2023…

Cancer awareness

Domain 5 – Addressing unwarranted variation in care

Palliative and end of life care action plan  

If you routinely hold the 16 palliative and end of life critical medicines, listed below, and can support local access to parenteral haloperidol…

You need to…

  • Update NHS Profile Manager – after 16th January 2023 (this is when NHS Profile Manager will be updated to allow this action) and by the end of 31st March 2023.
  • Have an action plan in place to use when you do not have the required stock of the 16 critical medicines or parenteral haloperidol available for a patient – action plan template available here – Action plan template (Word)
  • Please utilise your PCN Lead Whatsapp groups – Initiate conversations if you stock, plan to stock or don’t stock the medications.
  • For more information on your local PCN’s, please click here.

If you are not a stockholder of these 16 palliative and end of life critical medicines, you are not required to update NHS Profile Manager.

The 16 critical end of life medicines are:

  • Cyclizine solution for injection ampoules 50mg/1ml;
  • Cyclizine tablets 50mg;
  • Dexamethasone solution for injection ampoules 3.3mg/1ml;
  • Dexamethasone tablets 2mg;
  • Haloperidol tablets 500 mcg;
  • Hyoscine butylbromide solution for injection 20mg/1ml;
  • Levomepromazine solution for injection ampoules 25mg/1ml;
  • Metoclopramide solution for injection ampoules 10mg/2ml;
  • Midazolam solution for injection ampoules 10mg/2ml;
  • Morphine sulfate oral solution 10mg/5ml;
  • Morphine sulfate solution for injection ampoules 10mg/1ml;
  • Morphine sulfate solution for injection ampoules 30mg/1ml;
  • Oxycodone solution for injection ampoules 10mg/1ml;
  • Oxycodone oral solution sugar free 5mg/5ml;
  • Sodium chloride 0.9% solution for injection ampoules 10ml; and
  • Water for injections 10ml.

Action Plan needs to include…

  • an awareness of any locally commissioned services for palliative care including any on call and delivery arrangements;
  • a list of community pharmacies stocking the 16 critical medicines for palliative/end of life care in their area and noting the ability to check the Directory of Services (DoS) to find pharmacies stocking these medicines;
  • details of where parenteral haloperidol can be accessed locally, e.g. through any local commissioning arrangements; and
  • awareness of other support services that may be useful for patients/relatives/carers.
  • It must be available for inspection from the end of 31st March 2023 at premises level.

Here you will find details of palliative care services (in those areas where it is currently commissioned)

Pennine Lancashire (East Lancashire CCG & Blackburn with Darwen CCG)

Pennine Lancashire (East Lancashire CCG & Blackburn with Darwen CCG) Palliative Care Service – 01st March 2022 – 31st March 2023


Blackpool CCG and Fylde & Wyre CCG

Just in Case Service Specification – Fylde Coast – 01st April 2022 – 31st March 2023

Chorley & South Ribble and Greater Preston CCGs

Service specification 1st July 2020 – 31st December 2020 (Awaiting up to date information)

List of Pharmacies providing palliative care service in Chorley South Ribble & Greater Preston

Covid 19 Temporary End of Life Drugs list

Morecambe Bay CCG – Just in case

Just in Case (JIC) Service Specification 2021-22 (Awaiting up to date information)

West Lancashire CCG

Palliative Care Service Specification for community pharmacy – click here



Free Virtual Outcomes Link and Other Useful Links

CPPE training platform tells you which modules you need and don’t need to do based on when you completed them – https://www.cppe.ac.uk/services/pharmacy-quality-scheme
PSNC summary of Training Requirements – PSNC-Briefing-031.22-PQS-Summary-of-the-training-requirements-for-the-PQS-2022-23.pdf
PSNC briefing – Important Dates checklistPSNC-Briefing-037.22-CPCF-services-Important-dates-and-checklist-v4.pdf
Tally Sheet for PQS Markers to Ensure You Are Keeping On Track – https://psnc.org.uk/wp-content/uploads/20 22/10/Data-collection-form-PQS-2022-23.pdf Virtual Outcomes – Band new PQS training modules are available now – Pharmacy Training – Virtual Outcomes